| Budget Amount *help |
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2018: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
|
|---|
| Outline of Final Research Achievements |
This study aimed to develop a tool for assessing the self-management of patients with HTLV-1 associated myelopathy (HAM). The process of revealing the structure of the self-management of HAM patients took longer than expected; therefore, researcher is currently halfway through the designing phase of the self-management scale. Nevertheless, given that researcher have successfully clarified some of the characteristics of HAM patients which are not present in the self-management process in patients with other intractable neurological diseases, we are planning to continue engaging in this study with the hope of publishing the results as soon as possible.
|
